Kate Caves
KC
Kate Caves
CEO
Rate
About
Kate Caves is the CEO of Predicta Biosciences, a precision oncology company focused on developing non-invasive diagnostic and therapeutic products for blood cancers. She brings over a decade of senior corporate development experience from companies like 10x Genomics, Abcam, Zymergen, and Atum Bio. Predicta Biosciences aims to transform cancer diagnosis and treatment by providing detailed molecular data and identifying new drug targets.
Frequently asked
Who is Kate Caves?
Kate Caves is the CEO of Predicta Biosciences, a precision oncology company focused on developing non-invasive diagnostic and therapeutic products for blood cancers. She brings over a decade of senior corporate development experience from companies like 10x Genomics, Abcam, Zymergen, and Atum Bio. Predicta Biosciences aims to transform cancer diagnosis and treatment by providing detailed molecular…
What is Kate Caves's current role?
Kate Caves is currently CEO.
Comments
No comments yet. Be the first to share your take.
Profile
About Kate Caves
Kate Caves is CEO. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.